CST3 and metabolic syndrome: Higher EV-cystatin C levels were significantly related to a 57% higher prevalence of the metabolic syndrome (OR 1.57, 95% CI 1.19–2.27) while no relation was observed between the other EV markers and prevalence of the metabolic syndrome (Figure 3).